Cibus, Inc. (CBUS)

Market Cap	226.16M
Revenue (ttm)	2.32M
Net Income (ttm)	-285.67M
Shares Out	26.06M
EPS (ttm)	-25.38
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	167,736
Open	9.26
Previous Close	9.27
Day's Range	8.61 - 9.30
52-Week Range	8.31 - 24.61
Beta	1.92
Analysts	Strong Buy
Price Target	25.00 (+188.02%)
Earnings Date	Aug 7, 2024

About CBUS

Cibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. Cibus, Inc. is based in San Diego, California.

• Industry: Biotechnology
• Sector: Healthcare
• IPO Date: Jul 20, 2017
• Employees: 183
• Stock Exchange: NASDAQ
• Ticker Symbol: CBUS

Financial Performance

In 2023, Cibus's revenue was $1.82 million, an increase of 1057.32% compared to the previous year's $157,000. Losses were -$267.63 million, 1484.4% more than in 2022.

Analyst Forecast

According to one analyst, the rating for CBUS stock is "Strong Buy" and the 12-month stock price forecast is $25.0.

Price Target

$25.0

(188.02% upside)

Analyst Consensus: Strong Buy